Sutro Biopharma Inc
F:S090
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sutro Biopharma Inc
F:S090
|
US |
|
C
|
CIMC Enric Holdings Ltd
OTC:CIMEF
|
CN |
|
E
|
ESTsoft Corp
KOSDAQ:047560
|
KR |
|
G
|
Geiger Energy Corp
NEO:BEEP
|
CA |
|
AltPlus Inc
TSE:3672
|
JP |
|
O
|
Oceaneering International Inc
SWB:OII
|
US |
|
Penske Automotive Group Inc
F:UA9
|
US |
|
Industrias CH SAB de CV
F:AKQ
|
MX |
|
DKSH Holding AG
OTC:DKSHF
|
CH |
|
P
|
Perion Network Ltd
SWB:IW2
|
IL |
|
Okamura Corp
OTC:OKAMF
|
JP |
|
Mirarth Holdings Inc
OTC:TKLLF
|
JP |
|
S
|
Syrah Resources Ltd
OTC:SYAAF
|
AU |
|
Megaport Ltd
OTC:MGPPF
|
AU |
|
Ithaca Energy PLC
OTC:ITHLF
|
UK |
|
P
|
Pitney Bowes Inc
SWB:PBW
|
US |
|
Orient Overseas (International) Ltd
F:ORI1
|
HK |
|
S
|
SAP SE
XBSE:SAP
|
DE |
|
DMCI Holdings Inc
OTC:DMCIF
|
PH |
|
A
|
ALS Ltd
F:CP4
|
AU |
|
Black Diamond Therapeutics Inc
NASDAQ:BDTX
|
US |
|
A
|
Apollo Power Ltd
TASE:APLP
|
IL |
|
Blue Star Helium Ltd
OTC:BSNLD
|
AU |
|
1
|
111 Inc
XMUN:8110
|
CN |
Bankruptcy Probability
Sutro Biopharma Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sutro Biopharma Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sutro Biopharma Inc
NASDAQ:STRO
|
164.8m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
521B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
258.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
216.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
103.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
99.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sutro Biopharma Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sutro Biopharma Inc has total debt of 239.1m USD. This includes both short-term (0 USD) and long-term (239.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
